Renzo Canetta, M.D.
Former Vice President
Global R&D Oncology Policy, Bristol-Myers Squibb Company Research and Development
Dr. Canetta held numerous roles at Bristol-Myers Squibb (BMS), including head of clinical cancer research; head of development, life cycle management; vice president, oncology global clinical research; and vice president, global R&D oncology policy. His work resulted in the introduction of 18 new BMS drugs for general medical use and the approval of over 50 regulatory dossiers for additional indications/formulations including some outside of oncology.
Prior to his time at BMS, Dr. Canetta conducted clinical trials in lymphomas and gastrointestinal tumors at the Istituto Nazionale Tumori in Milan. He retired from BMS in August 2015.